Form D · Pharmaceuticals
Star Biologics, Inc.
Houston, TX · CIK 0001542858
Offering snapshot reported Feb 24, 2012 · SEC filing
- Reported sold
- $65K Offering amount: $200K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jan 13, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 24, 2012 | Initial | $65,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173957
Source: Form D, filed Feb 24, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Vazquez | Director, Executive |
| Lawrence Michael Wunderlich | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11152 Westheimer Rd., # 718
Houston, TX, 77042
Houston, TX, 77042